
The management of zzso disease remains one of the most challenging areas of modern zzso The lifetime risk of developing cancer in the western world is estimated to be as high as 1 in zzso Traditionally, surgery, chemotherapy and zzso have been the primary choice of treatment for patients with zzso zzso Despite advances in the use and development of conventional zzso agents, the cure rate remains disappointing in most patients with advanced disease of the common solid zzso zzso the development of novel zzso therapies is a high priority in cancer zzso In recent years, a new generation of cancer therapies has emerged, based on a growing understanding of the molecular events that contribute to zzso zzso A major difference between normal and cancer cells is the ability of cancer cells to multiply in an unrestricted and zzso zzso In this context, there is considerable interest in zzso the mechanisms that allow this unrestricted proliferation and that ultimately result in zzso cancer zzso It is now clear that the zzso zzso zzso zzso on cells in most types of zzso With the cancer cell zzso on zzso for its survival, zzso represents an extremely attractive zzso target for the development of new cancer zzso 

